DCF — PROVIDENCE ST JOSEPH MEDICAL CENTER
Enterprise Value: $-406.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-406.3M
Enterprise Value
$-135.9M
PV of Cash Flows
$-270.4M
PV of Terminal Value
$-435.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $473.2M | $-21.3M | -4.0% | $-41.3M | $-37.6M |
| Year 2 | $487.4M | $-17.1M | -3.0% | $-37.7M | $-31.2M |
| Year 3 | $502.0M | $-12.6M | -2.0% | $-33.8M | $-25.4M |
| Year 4 | $517.1M | $-10.3M | -2.0% | $-32.2M | $-22.0M |
| Year 5 | $532.6M | $-9.3M | -2.0% | $-31.9M | $-19.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-406.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$459.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.049999999782342874
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5